Clinical Trials on Cancer Cachexia in Hong Kong

Total 1006 results

The Hong Kong Polytechnic University

Completed

A BHI to Increase Hope Level and Stress Level of Parents With a CMC

Endocrine System Diseases | Muscular Atrophy, Spinal | Child With Cancer | Child With Cerebral Palsy

China
Arbele Pty Ltd

Recruiting

Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer Patients

Gastric Cancer | Pancreatic Cancer | Cholangiocarcinoma | Esophageal Adenocarcinoma | Gastrointestinal Cancer | Liver Cancer | Colorectal Adenocarcinoma | Gastroesophageal Junction

Hong Kong, Australia
Chinese University of Hong Kong

Not yet recruiting

Mesothelin-targeted CAR-T Cells as a Neo-adjuvant Treatment in Patients With Resectable Pancreatic Cancers: a Feasibility Study (CART)

Pancreatic Cancer

Hong Kong
Chinese University of Hong Kong

Completed

Safety & Effectiveness of Nurse Performed Colonoscopies Under Supervision

Colorectal Cancer

Hong Kong
Chinese University of Hong Kong

Completed

A Follow-up Colonoscopy Examination in Patients Who Had Previously Undergone Screening Colonoscopy

Colonic Cancer

China
Chinese University of Hong Kong

Recruiting

Patient and Physician Benefit/ Risk Preferences for Treatment of mPC in Hong Kong: a Discrete Choice Experiment

Prostate Cancer

Hong Kong
Chinese University of Hong Kong

Completed

The Effect of Androgen Deprivation Therapy on Gut and Urinary Microbiota in Patients With Prostate Cancer

Prostate Cancer

Hong Kong
Medtronic - MITG

Completed

Clinical Description of a Bronchoscopic Approach to Ablate Lung Nodules Using the Emprint™ Ablation Catheter (NAVABLATE)

Cancer, Lung | Cancer, Metastatic to Lung

Hong Kong, United Kingdom
Chinese University of Hong Kong

Recruiting

A Multi-centre Trial on Targeted Microwave Ablation (TMA) for Localized Prostate Cancer

Prostate Cancer

Hong Kong
The University of Hong Kong

Recruiting

The Long-term Spill-over Impact of COVID-19 on Health and Healthcare of People With Non-communicable Diseases

Cardiovascular Diseases | Hypertension | Diabetes Mellitus | Cancer | Kidney Disease, Chronic | Noncommunicable Diseases | Chronic Respiratory Disease

China
Chinese University of Hong Kong

Unknown

Endolaparoscopic Versus Immediate Surgery for Obstructing Colorectal Cancers

Colorectal Cancer | Bowel Obstruction

China
Chinese University of Hong Kong

Active, not recruiting

Appendectomy and Colorectal Cancer

Colorectal Cancer | Appendicitis

Hong Kong
Chinese University of Hong Kong
Ipsen

Completed

Retrospective Study to Assess Real-Life Use of The Long Acting GnRH Agonist as Prostate Cancer Treatment

Prostate Cancer

Hong Kong
Chinese University of Hong Kong

Completed

Factors Affecting Androgen Deprivation Therapy Choice in Prostate Cancer Patients

Prostate Cancer

Hong Kong
Chinese University of Hong Kong

Completed

Safety and Tumoricidal Effect of Low Dose Foscan PDT in Patients With Inoperable Bile Duct Cancers (PDT)

Cholangiocarcinoma | Klatskin Tumor | Tumor

Hong Kong
The University of Hong Kong
Chinese University of Hong Kong

Completed

Acupuncture Prevents Chemobrain in Breast Cancer Patients

Breast Cancer | Mild Cognitive Impairment | Drug-Related Side Effects and Adverse Reactions | Chemo-brain

China, Hong Kong
The University of Hong Kong
The Family Planning Association of Hong Kong

Unknown

HPV-cytology Testing Versus Cytology Testing for the Detection of High Grade CIN (COCY)

Cervical Cancer | Cervical Intraepithelial Neoplasia

China
Chinese University of Hong Kong

Not yet recruiting

Clinical Outcomes After EMR or ESD of Colorectal Neoplasms - A Multicenter Registry

Colorectal Neoplasms | Colorectal Cancer | Colorectal Adenoma

Hong Kong
Princess Margaret Hospital, Hong Kong

Completed

Adrenal Function in Patients With Newly Diagnosed Lung Cancer

Lung Cancer | Adrenal Insufficiency

China
Chinese University of Hong Kong

Enrolling by invitation

Subpectoral Plexus Block With Multi-level TPVB for Surgical Anesthesia During Primary Breast Cancer Surgery

Breast Cancer

Hong Kong
Chinese University of Hong Kong

Recruiting

Serial Gut Microbiome and Bacterial Gene Markers Changes After Endoscopic Resection of Colorectal Advanced Neoplasia (M3-CAN)

Colorectal Neoplasms | Colorectal Cancer | Colorectal Adenoma

Hong Kong
Chinese University of Hong Kong

Recruiting

Prediction of Gastric Cancer in Intestinal Metaplasia and Atrophic Gastritis (GIMA)

Gastric Cancer | Intestinal Metaplasia | Atrophic Gastritis

Hong Kong
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)

Completed

Heat Activated Liposomal Doxorubicin and Radiofrequency Ablation in Treating Patients With Primary or Metastatic Liver Tumors

Metastatic Cancer | Liver Cancer

United States, China
Chinese University of Hong Kong

Completed

Study on Second Forward View Examination in the Right Colon

Colorectal Cancer | Colonic Polyp

Hong Kong
Chinese University of Hong Kong

Recruiting

A Novel Oral Synbiotic Formula in Reducing Adenoma Recurrence and Colorectal Neoplasia-related Bacterial Gene Markers

Colorectal Neoplasms | Colorectal Cancer | Colorectal Adenoma

Hong Kong
National University Hospital, Singapore
Prince of Wales Hospital, Shatin, Hong Kong; Apollo Gleneagles Hospitals, Kolkata

Unknown

Safety and Efficacy of Using MASTER to Perform Endoscopic Submucosal Dissection in Human

Gastric Cancer | Colon Cancer

Singapore, India, China
National Healthcare Group, Singapore
Chinese University of Hong Kong; Tan Tock Seng Hospital; Changi General Hospital

Completed

A Study Comparing Billroth II With Roux-en-Y Reconstruction for Gastric Cancer (SCAR)

Stomach Cancer | Gastric Cancer | Gastrectomy

Singapore, Hong Kong
Galvanize Therapeutics, Inc.

Terminated

A Clinical Evaluation of the Aliya™ System in Late Stage Cancer (INCITE LS)

Cancer of Lung, Kidney or Liver

Hong Kong, Spain, Netherlands
Hoffmann-La Roche

Completed

A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) in Patients With Advanced or Metastatic Liver Cancer

Liver Cancer

Hong Kong, Taiwan, Singapore, Australia
Shanghai Chest Hospital
Chang Gung Memorial Hospital; Tianjin Medical University Cancer Institute and... and other collaborators

Unknown

Pre-Surgery If Needed for Oesophageal Cancer (preSINO)

Esophageal Cancer

China, Hong Kong, Taiwan
Galvanize Therapeutics, Inc.

Active, not recruiting

Feasibility Study of the Aliya System in the Treatment of Early Stage Non-small Cell Lung Cancer (INCITE ES)

Non Small Cell Lung Cancer

Hong Kong, Spain, Netherlands
Chinese University of Hong Kong

Recruiting

AG & IM in CA Stomach Protocol

Gastric Cancer | Intestinal Metaplasia | Atrophic Gastritis

Hong Kong, Japan, Singapore, Thailand
Chinese University of Hong Kong

Completed

The Effect of Andrographis Paniculata (AP) on Palliative Management of Advanced Esophageal Cancer (AP)

Squamous Cell Carcinoma of Esophagus

China
National Cancer Centre, Singapore
Guardant Health AMEA, Inc.

Recruiting

Plasma Molecular Profiling in ALK Inhibitor Resistant NSCLC

Non-small Cell Lung Cancer | ALK-Positive Lung Cancer

Korea, Republic of, Hong Kong, Malaysia, Singapore
AstraZeneca

Completed

Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Efficacy of Tor Kinase Inhibitor in Liver Cancer Patients

Cancer | Advanced Hepatocellular Carcinoma

Korea, Republic of, Hong Kong
PROCEPT BioRobotics

Recruiting

PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTs

Benign Prostatic Hyperplasia | Localized Prostate Cancer

Lebanon, Hong Kong, United States
Matrix Pharmaceutical

Unknown

Chemotherapy in Treating Patients With Liver Cancer

Liver Cancer

United States, Hong Kong
GlaxoSmithKline

Completed

Pilot Study of Patient's Adherence to TYKERB™/TYVERB™ + Capecitabine in Metastatic Breast Cancer

Cancer

Korea, Republic of, Hong Kong, Pakistan, Singapore
Chinese University of Hong Kong
Changi General Hospital; Kosin University Gospel Hospital; Shizuoka Cancer Center and other collaborators

Completed

RCT of Gastric ESD With or Without Epineprhine Added Solution

Early Gastric Cancer | Gastric Neoplasm

Japan, Singapore, Korea, Republic of, Hong Kong
Bayer

No longer available

Expanded Access to Provide Copanlisib for Patients With Cancer Who Are Experiencing a Positive Response, as Determined by Their Doctors

Cancer

Brazil, Hong Kong, Hungary, Malaysia, Poland, Romania, Russian Federation, Taiwan, Ukraine, Ireland, Chile
Servier Bio-Innovation LLC
Regeneron Pharmaceuticals; Institut de Recherches Internationales Servier

Not yet recruiting

Phase 1b/2 Platform Study of Select Immunotherapy Combinations in Participants With Advanced Non-small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer (NSCLC)

Hong Kong, United States, Australia
Novartis Pharmaceuticals

Completed

An East Asian Study of LDE225

Medulloblastoma | Basal Cell Carcinoma | Advanced Solid Tumor Cancers

Taiwan, Hong Kong, Japan
University of Washington
National Cancer Institute (NCI); National Institutes of Health (NIH)

Terminated

MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical Cancer

Cervical Adenocarcinoma | Cervical Adenosquamous Carcinoma | Cervical Squamous Cell Carcinoma, Not Otherwise Specified | Recurrent Cervical Carcinoma | Cervical Undifferentiated Carcinoma | Stage IIA Cervical Cancer | Stage IIB Cervical Cancer | Stage III Cervical Cancer | Stage IVA Cervical Cancer | Stage... and other conditions

United States, Hong Kong, Canada
Hoffmann-La Roche

Completed

A Study of Capecitabine (Xeloda) as First-Line Chemotherapy in Participants With Metastatic Nasopharyngeal Cancer

Nasopharyngeal Cancer

Hong Kong, Thailand, Indonesia, Taiwan, Malaysia
Cancer Therapeutics Research Group
National Cancer Institute (NCI)

Completed

Fenretinide In Treating Patients With Advanced or Metastatic Hormone-Refractory Prostate Cancer

Prostate Cancer

Australia, Singapore, Hong Kong
Cancer Therapeutics Research Group
National Cancer Institute (NCI)

Completed

Irofulven in Treating Patients With Recurrent or Metastatic Gastric Cancer

Gastric Cancer

Australia, Singapore, Hong Kong, Korea, Republic of
National Cancer Centre, Singapore
Pfizer

Active, not recruiting

Phase 2 Study of Dacomitinib in NSCLC

NSCLC Stage IV | NSCLC Stage IIIB | Recurrent NSCLC | NSCLC Stage IIIC | EGFR Positive Non-Small Cell Lung Cancer

Korea, Republic of, Hong Kong, Thailand, Singapore, Malaysia
Progen Pharmaceuticals

Terminated

Phase III Study of PI-88 in Post-resection Hepatocellular Carcinoma (PATHWAY)

Cancer | Hepatocellular Carcinoma | Primary Liver Cancer | Liver Cancer | Hepatoma

Hong Kong, Singapore, United States, Australia, Canada, Italy, Malaysia, Spain, Taiwan, Thailand
Cullinan Oncology, LLC
National Cancer Institute (NCI)

Terminated

Phase 1/2a Study of VK-2019 in Patients With Epstein-Barr Virus (EBV)-Positive Nasopharyngeal Carcinoma (NPC)

Nasopharyngeal Carcinoma | Nasopharyngeal Cancer

France, Singapore, United States, China, Hong Kong
National Cancer Centre, Singapore
Singapore General Hospital

Recruiting

Molecular Profiling Project

Non-Small Cell Lung Cancer | Lung Cancer

Thailand, Singapore, Hong Kong, Brunei Darussalam, India, Malaysia

Clinical Trials on Cancer Cachexia in Hong Kong

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Azerbaijan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations